About CSI Laboratories
CSI Laboratories is a company based in Alpharetta (United States) founded in 2011 by Ron Ghafary was acquired by Fulgent Genetics in August 2021. CSI Laboratories offers products and services including Lumera NGS Profile and Lumera Liquid Biopsy.
- Headquarter Alpharetta, United States
- Founders Ron Ghafary
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fulgent Genetics
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Fulgent Genetics
& 1 more
-
Employee Count
Not available
-
Acquired by
Fulgent Genetics
(Aug 09, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CSI Laboratories
CSI Laboratories offers a comprehensive portfolio of products and services, including Lumera NGS Profile and Lumera Liquid Biopsy.
Next-generation sequencing is utilized for personalized cancer testing, including solid tumor analysis and clinical case reviews
Liquid biopsy testing is provided for non-invasive cancer monitoring and genomic analysis
People of CSI Laboratories
Unlock access to complete
Funding Insights of CSI Laboratories
Investors in CSI Laboratories
CSI Laboratories has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Fulgent Genetics and Synergy Capital Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Synergy Capital Investments is engaged in private equity and business acquisition.
|
Locked | Locked | Locked | |
|
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer
|
Locked | Locked | Locked |
Investor details for CSI Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CSI Laboratories
Investment portfolio details for CSI Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CSI Laboratories
Detailed financials for CSI Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Csi Laboratories Comparisons
Peer comparison for CSI Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CSI Laboratories
Detailed competitors of CSI Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Csi Laboratories
Complete news archive for CSI Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CSI Laboratories
CSI Laboratories was founded in 2011 and raised its 1st funding round 8 years after it was founded.
CSI Laboratories is headquartered in Alpharetta, United States. It is registered at Alpharetta, Georgia, United States.
Ron Ghafary is the current CEO of CSI Laboratories. They have also founded this company.
CSI Laboratories was founded in 2011 and operates as a standalone pathology lab in Alpharetta, United States. Diagnostic services in pathology are provided through its facilities, focusing on clinical testing and analysis. The company is led by founder and CEO Ron Ghafary, with operations centered on healthcare diagnostics in the medical sector. Accessibility is maintained via the domain csilaboratories.com for client interactions.
CSI Laboratories offers Lumera NGS Profile and Lumera Liquid Biopsy.
CSI Laboratories has 2 investors. Key investors include Fulgent Genetics, and Synergy Capital Investments.